Close Menu

NEW YORK – Interpace Diagnostics said after the close of the market on Wednesday that its third quarter revenues increased 33 percent year over year.

The Parsippany, New Jersey-based firm also announced that it has changed its name to Interpace Biosciences to better reflect its new business model combining esoteric molecular diagnostic testing with the new drug discovery and development services business it acquired from Cancer Genetics in July.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Following its departure from the European Union, the UK is to implement a fast-track visa program aimed at attracting scientific talent to Britain, according to BBC News.

The Washington Post reports that researchers are quickly analyzing the coronavirus that has been causing illness and sharing their findings.

ScienceInsider reports that researchers in Brazil are concerned that a creationist was chosen to run the agency that oversees graduate study programs there.

In PLOS this week: common variant associated with BMI in Arctic populations, analysis of microRNA markers associated with being born small for gestational age, and more.